← Oncology Approval Tracker

FDA DECISION ·

Pemetrexed injection (Shilpa)

pemetrexed disodium · Shilpa Medicare

FDA approvalNew formulationNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

An IV solution for specified first-line, maintenance and post-chemotherapy nonsquamous NSCLC uses and initial use with cisplatin for malignant pleural mesothelioma when curative surgery is unsuitable.

LAMPGEN ANALYSIS

Why it matters

The new solution presentation adds a preparation option for existing pemetrexed regimens.

What research teams should watch

Check molecular eligibility and the intended combination, then verify dilution, folate and vitamin B12 procedures.

PRIMARY RECORDS

Sources